Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma.

Sci Rep · 2019 · PMC6533291 · PMID 31123336

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

failed to reach statistical significancep > 0.05actually significant

Also, coefficients such as: bone metastases, time between nephrectomy and treatment start or the size of extranodal metastases greater than 8.0 cm failed to reach statistical significance (p > 0.05) for OS impact.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.